Centrose Overview

  • Year Founded
  • 2006

Year Founded

  • Status
  • Private

  • Employees
  • 12

Employees

  • Latest Deal Type
  • Later Stage VC

  • Latest Deal Amount
  • $100K

  • Investors
  • 5

Centrose General Information

Description

Developer of antibody-drug conjugates designed to fight life-threatening diseases. The company offers precision drugs, extracellular drug conjugates, bring therapies to treat advanced forms of cancer and other difficult-to-treat diseases, enabling health institutes to improve disease treatment with precision.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 1600 Aspen Commons
  • Suite 101
  • Middleton, WI 53562
  • United States
+1 (608)
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
Life Sciences, Oncology
Corporate Office
  • 1600 Aspen Commons
  • Suite 101
  • Middleton, WI 53562
  • United States
+1 (608)

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Centrose Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
9. Later Stage VC 10-Sep-2019 $100K Completed Generating Revenue
8. Later Stage VC 10-Aug-2017 Completed Generating Revenue
7. Later Stage VC 01-Jun-2015 Completed Generating Revenue
6. Grant 01-Jan-2014 Completed Generating Revenue
5. Later Stage VC 01-Jan-2012 Completed Generating Revenue
4. Angel (individual) 08-Sep-2011 Completed Startup
3. Angel (individual) 19-Feb-2009 Completed Startup
2. Angel (individual) 14-Feb-2008 $1.3M $2.17M Completed Startup
1. Angel (individual) 07-Sep-2007 $875K $875K Completed Startup
To view Centrose’s complete valuation and funding history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Centrose Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of antibody-drug conjugates designed to fight life-threatening diseases. The company offers precision drugs, e
Drug Discovery
Middleton, WI
12 As of 2015

Philadelphia, PA
 

Gaithersburg, MD
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Centrose Competitors (43)

One of Centrose’s 43 competitors is Aro Biotherapeutics, a Venture Capital-Backed company based in Philadelphia, PA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Aro Biotherapeutics Venture Capital-Backed Philadelphia, PA
NexImmune Formerly VC-backed Gaithersburg, MD
Rein Therapeutics Formerly VC-backed Austin, TX
Arvinas Formerly VC-backed New Haven, CT
CytImmune Sciences Private Equity-Backed Rockville, MD
You’re viewing 5 of 43 competitors. Get the full list »

Centrose Patents

Centrose Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20170049908-A1 Extracellular targeted drug conjugates Inactive 17-Aug-2015
EP-3328393-A1 Extracellular drug conjugates targeting cd20 Active 31-Jul-2015
US-20190008983-A1 Extracellular drug conjugates targeting cd20 Inactive 31-Jul-2015
EP-3328393-A4 Extracellular drug conjugates targeting cd20 Active 31-Jul-2015
EP-3328393-B1 Extracellular drug conjugates targeting cd20 Active 31-Jul-2015 A61K47/6849
To view Centrose’s complete patent history, request access »

Centrose Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Centrose Investors (5)

Investor Name Investor Type Holding Investor Since Participating Rounds
Wisconsin Economic Development Government Minority
National Science Foundation Government
U.S. Department of Health and Human Services Government
Pavek Investments Other Minority
Wisconsin Investment Partners Angel Group Minority
To view Centrose’s complete investors history, request access »

Centrose FAQs

  • When was Centrose founded?

    Centrose was founded in 2006.

  • Where is Centrose headquartered?

    Centrose is headquartered in Middleton, WI.

  • What is the size of Centrose?

    Centrose has 12 total employees.

  • What industry is Centrose in?

    Centrose’s primary industry is Drug Discovery.

  • Is Centrose a private or public company?

    Centrose is a Private company.

  • What is Centrose’s current revenue?

    The current revenue for Centrose is .

  • How much funding has Centrose raised over time?

    Centrose has raised $26.5M.

  • Who are Centrose’s investors?

    Wisconsin Economic Development, National Science Foundation, U.S. Department of Health and Human Services, Pavek Investments, and Wisconsin Investment Partners have invested in Centrose.

  • Who are Centrose’s competitors?

    Aro Biotherapeutics, NexImmune, Rein Therapeutics, Arvinas, and CytImmune Sciences are some of the 43 competitors of Centrose.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »